184 related articles for article (PubMed ID: 19073519)
21. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
22. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
23. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
24. The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer.
Huang G; Song H; Wang R; Han X; Chen L
J Surg Oncol; 2012 Mar; 105(4):420-4. PubMed ID: 21780128
[TBL] [Abstract][Full Text] [Related]
25. Maspin expression in oral squamous cell carcinoma.
Iezzi G; Piattelli A; Rubini C; Goteri G; Artese L; Perrotti V; Carinci F
J Craniofac Surg; 2007 Sep; 18(5):1039-43. PubMed ID: 17912078
[TBL] [Abstract][Full Text] [Related]
26. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
[TBL] [Abstract][Full Text] [Related]
27. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
[TBL] [Abstract][Full Text] [Related]
28. HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients.
Scieglinska D; Gogler-Piglowska A; Butkiewicz D; Chekan M; Malusecka E; Harasim J; Habryka A; Krawczyk Z
Anticancer Res; 2014 Jun; 34(6):2833-40. PubMed ID: 24922646
[TBL] [Abstract][Full Text] [Related]
29. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.
Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR
Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735
[TBL] [Abstract][Full Text] [Related]
30. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
Porebska I; Sobańska E; Kosacka M; Jankowska R
Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
[TBL] [Abstract][Full Text] [Related]
32. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
Warnecke-Eberz U; Bollschweiler E; Drebber U; Pohl A; Baldus SE; Hoelscher AH; Metzger R
Oncol Rep; 2008 Sep; 20(3):619-24. PubMed ID: 18695914
[TBL] [Abstract][Full Text] [Related]
33. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
34. Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Wu S; Yu L; Cheng Z; Song W; Zhou L; Tao Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):346-352. PubMed ID: 22684556
[TBL] [Abstract][Full Text] [Related]
35. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
Hastings RH; Laux AM; Casillas A; Xu R; Lukas Z; Ernstrom K; Deftos LJ
Clin Cancer Res; 2006 Jan; 12(2):499-506. PubMed ID: 16428492
[TBL] [Abstract][Full Text] [Related]
36. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
37. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H
Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817
[TBL] [Abstract][Full Text] [Related]
38. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA
Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485
[TBL] [Abstract][Full Text] [Related]
39. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
[TBL] [Abstract][Full Text] [Related]
40. [Mammary serine proteinase inhibitor subcellular expression in oral squamous cell carcinoma and its clinical significance].
Luo J; Shu HR; Ying YK; Wu WL; Ji T; Zhong LP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):505-9. PubMed ID: 22169751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
